NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET

7.1 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Mallinckrodt PLC

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Advanced Accelerator Applications SA

16.3 Lantheus Medical Imaging Inc

16.4 GE Healthcare

16.5 Eczacibasi-Monrol Nuclear Products

16.6 Nordion Inc

16.7 Cardinal Health Inc

16.8 Bracco Imaging SPA

16.9 Iba Molecular

16.10 Bayer AG

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER